Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2025-12-24 @ 4:14 PM
NCT ID:
NCT00080366
Eligibility Criteria:
* INCLUSION CRITERIA:
14 patients with a clinical diagnosis of essential tremor will participate in the study. Selection criterion is essential tremor with a history of ethanol responsiveness. Informed consent will be obtained by any of the co-investigators.
Patients must be off any medications used to treat essential tremor such as mysoline or propranolol for at least 2 weeks. Patients must withhold ethanol and caffeine 24 hours prior to starting the treatment periods through the end of treatment periods, including alcohol or caffeine containing over the counter medications. Ethanol and caffeine consumption is allowed in the washout period.
EXCLUSION CRITERIA:
Patients with abnormalities on neurologic exam other than tremor.
Patients with a history of chronic alcohol dependence.
Patients with chronic medical conditions such as renal failure, hepatic failure and chronic lung disease.
Patients on other medications that cannot be temporarily discontinued for the length of the study.
Patients, who, for moral or religious reasons, do not wish to take a potentially intoxicating drug.
Patients with abnormalities on their baseline screening laboratory tests.
Women who are pregnant or lactating.
Patients under the age of 21.
Asians and Pacific Islanders.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Study:
NCT00080366
Study Brief:
Protocol Section:
NCT00080366